Koichi Kikuta

486 total citations
15 papers, 354 citations indexed

About

Koichi Kikuta is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Koichi Kikuta has authored 15 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 5 papers in Cardiology and Cardiovascular Medicine and 3 papers in Surgery. Recurrent topics in Koichi Kikuta's work include Respiratory Support and Mechanisms (6 papers), Neonatal Respiratory Health Research (3 papers) and Heart Failure Treatment and Management (3 papers). Koichi Kikuta is often cited by papers focused on Respiratory Support and Mechanisms (6 papers), Neonatal Respiratory Health Research (3 papers) and Heart Failure Treatment and Management (3 papers). Koichi Kikuta collaborates with scholars based in Japan. Koichi Kikuta's co-authors include Ichiro Kukita, Hirofumi Yasue, Masamichi Hamaguchi, Kazuwa Nakao, Etsuo Morita, Kazufumi Okamoto, Ken Okumura, Kiyotaka Kugiyama, Hitoshi Sumida and Kozaburo Matsuyama and has published in prestigious journals such as Journal of the American College of Cardiology, CHEST Journal and Critical Care Medicine.

In The Last Decade

Koichi Kikuta

14 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Koichi Kikuta Japan 8 217 97 54 40 39 15 354
Leroy J. Hirsch United States 9 172 0.8× 104 1.1× 69 1.3× 73 1.8× 29 0.7× 18 349
Finn Michael Karlsen Denmark 11 289 1.3× 52 0.5× 66 1.2× 49 1.2× 51 1.3× 16 432
Bernard Lambermont Belgium 10 199 0.9× 97 1.0× 125 2.3× 30 0.8× 24 0.6× 26 324
Mehmet Akif Düzenli Türkiye 13 341 1.6× 43 0.4× 65 1.2× 12 0.3× 102 2.6× 36 408
Krishnamurti Rao United States 6 363 1.7× 149 1.5× 41 0.8× 20 0.5× 10 0.3× 7 439
Bjarni Torfason Iceland 11 259 1.2× 129 1.3× 131 2.4× 27 0.7× 11 0.3× 25 448
Kambiz Shahgaldi Sweden 12 364 1.7× 131 1.4× 77 1.4× 14 0.3× 125 3.2× 36 442
D. W. Riddington United Kingdom 5 133 0.6× 81 0.8× 211 3.9× 28 0.7× 9 0.2× 7 378
Adrienne Newburg United States 8 70 0.3× 78 0.8× 69 1.3× 14 0.3× 39 1.0× 16 320
Fotis Kardaras Greece 10 254 1.2× 41 0.4× 90 1.7× 11 0.3× 90 2.3× 21 341

Countries citing papers authored by Koichi Kikuta

Since Specialization
Citations

This map shows the geographic impact of Koichi Kikuta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koichi Kikuta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koichi Kikuta more than expected).

Fields of papers citing papers by Koichi Kikuta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koichi Kikuta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koichi Kikuta. The network helps show where Koichi Kikuta may publish in the future.

Co-authorship network of co-authors of Koichi Kikuta

This figure shows the co-authorship network connecting the top 25 collaborators of Koichi Kikuta. A scholar is included among the top collaborators of Koichi Kikuta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koichi Kikuta. Koichi Kikuta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Yamamoto, Eiichiro, Hiroki Usuku, Daisuke Sueta, et al.. (2024). Efficacy and Safety of Esaxerenone in Hypertensive Patients with Left Ventricular Hypertrophy (ESES-LVH) Study: A Multicenter, Open-Label, Prospective, Interventional Study. Advances in Therapy. 41(3). 1284–1303. 10 indexed citations
2.
Ishii, Yumi, Kunio Yufu, Tetsuji Shinohara, et al.. (2017). Congenital Ostial Atresia of the Left Anterior Descending Artery. Circulation Journal. 81(10). 1550–1552.
3.
Sakamoto, Tomohiro, Hisao Ogawa, Kōichi Nakao, et al.. (2015). Impact of candesartan on cardiovascular events after drug-eluting stent implantation in patients with coronary artery disease: The 4C trial. Journal of Cardiology. 67(4). 371–377. 2 indexed citations
4.
Sakamoto, Tomohiro, Hisao Ogawa, Kōichi Nakao, et al.. (2013). Rationale, Design and Baseline Characteristics of a Study to Evaluate Effects of Candesartan on Cardiovascular Events after Drug-eluting Stent Implantation in Patients with Ischemic Heart Disease. Journal of Atherosclerosis and Thrombosis. 20(5). 472–480. 1 indexed citations
5.
Okamoto, Kazufumi, Ichiro Kukita, Masamichi Hamaguchi, et al.. (2000). Combination of Inhaled Nitric Oxide Therapy and Inverse Ratio Ventilation in Patients with Sepsis-Associated Acute Respiratory Distress Syndrome. Artificial Organs. 24(11). 902–908. 1 indexed citations
6.
Moriyama, Shuji, Kazufumi Okamoto, Koichi Kikuta, et al.. (1999). Evaluation of oxygen consumption and resting energy expenditure in critically ill patients with systemic inflammatory response syndrome. Critical Care Medicine. 27(10). 2133–2136. 52 indexed citations
7.
Sato, Toshihide, et al.. (1999). The Pharmacokinetics of Ceftazidime During Hemodiafiltration in Critically Ill Patients. Artificial Organs. 23(2). 143–145. 13 indexed citations
8.
Hamaguchi, Masamichi, et al.. (1998). Efficacy of Inhaled Nitric Oxide in Children With ARDS. CHEST Journal. 114(3). 827–833. 37 indexed citations
9.
Shibata, Yoshihiro, Kazufumi Okamoto, Ichiro Kukita, Koichi Kikuta, & Toshihide Sato. (1997). The safety of a nitric oxide inhalation system with high frequency oscillatory ventilation. Pediatrics International. 39(2). 176–180. 2 indexed citations
10.
Sato, Toshihide, Kazufumi Okamoto, Ichiro Kukita, et al.. (1997). Nitrogen dioxide production in a nitric oxide inhalation system using the Servo Ventilator 900C. Pediatrics International. 39(2). 172–175. 7 indexed citations
11.
Shibata, Yoshihiro, Kazufumi Okamoto, Toshihide Sato, Ichiro Kukita, & Koichi Kikuta. (1996). The safety of a nitric oxide inhalation system using a conventional infant respirator. Pediatrics International. 38(2). 143–146. 3 indexed citations
12.
Kikuta, Koichi, Hirofumi Yasue, Michihiro Yoshimura, et al.. (1996). Increased plasma levels of B-type natriuretic peptide in patients with unstable angina. American Heart Journal. 132(1). 101–107. 107 indexed citations
13.
Kukita, Ichiro, et al.. (1996). Evaluation of Mapleson systems for administration of inhaled nitric oxide. Journal of Anesthesia. 10(1). 44–48. 7 indexed citations
14.
Okumura, Ken, Hirofumi Yasue, Hiromi Fujii, et al.. (1995). Effect of brain (B-type) natriuretic peptide on coronary artery diameter and coronary hemodynamic variables in humans: Comparison with effects on systemic hemodynamic variables. Journal of the American College of Cardiology. 25(2). 342–348. 37 indexed citations
15.
Yasue, Hirofumi, Kiyotaka Kugiyama, Kozaburo Matsuyama, et al.. (1995). Comparison of secretion pattern between A-type and B-type natriuretic peptides in patients with old myocardial infarction. Journal of the American College of Cardiology. 25(5). 1105–1110. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026